We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
+4.67%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$16.6M
AUM Growth
-$9.9B
(-100%)
Cap. Flow
-$129M
Cap. Flow
% of AUM
-776.34%
Top 10 Holdings %
Top 10 Hldgs %
44.31%
Holding
282
New
27
Increased
109
Reduced
88
Closed
26
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
|
+$68M |
| 2 |
eBay
EBAY
|
+$60.2M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$55.9M |
| 4 |
Cognizant
CTSH
|
+$54.2M |
| 5 |
SS&C Technologies
SSNC
|
+$45.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$56.6M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$49.2M |
| 3 |
Elevance Health
ELV
|
+$44.3M |
| 4 |
Apple
AAPL
|
+$41.2M |
| 5 |
Abbott
ABT
|
+$38.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.69% |
| 2 | Financials | 13.93% |
| 3 | Healthcare | 11.89% |
| 4 | Communication Services | 7.22% |
| 5 | Industrials | 5.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Nutanix
NTNX
$14.9B
| $32.5K | 0.2% |
630,883
+134,100
| +27% | +$7.37M |
|
102
ICU Medical
ICUI
$3.93B
| $32.5K | 0.2% |
110,515
-14,491
| -12% | -$3.96M |
|
|
OXFD
103
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
| $32.2K | 0.19% |
2,500,022
| – | – |
|
|
QTNT
104
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $32K | 0.19% |
99,768
-13,414
| -12% | -$3.14M |
|
|
TWOU
105
DELISTED
2U Inc
TWOU
| $31.3K | 0.19% |
12,479
+2,525
| +25% | +$6.7M |
|
106
8x8 Inc
EGHT
$247M
| $31.1K | 0.19% |
1,550,501
-394,924
| -20% | -$7.88M |
|
107
Baxter International
BAX
$11.6B
| $31.1K | 0.19% |
421,000
-359,000
| -46% | -$25.3M |
|
108
Twilio
TWLO
$29.1B
| $31.1K | 0.19% |
554,404
-205,049
| -27% | -$10.2M |
|
109
Dropbox
DBX
$6.81B
| $31K | 0.19% |
957,536
+856,536
| +848% | +$26.8M |
|
110
HubSpot
HUBS
$10.5B
| $30.8K | 0.19% |
245,788
-53,409
| -18% | -$6.33M |
|
|
STML
111
DELISTED
Stemline Therapeutics, Inc.
STML
| $30.7K | 0.18% |
1,912,605
+1,539,320
| +412% | +$27.5M |
|
|
112
Vertex Pharmaceuticals
VRTX
$121B
| $29.7K | 0.18% |
175,000
-317,500
| -64% | -$49.2M |
|
113
Affiliated Managers Group
AMG
$9.46B
| $29.5K | 0.18% |
198,654
+30,914
| +18% | +$5.1M |
|
|
PFPT
114
DELISTED
Proofpoint, Inc.
PFPT
| $29.3K | 0.18% |
254,293
-94,754
| -27% | -$11.5M |
|
115
Carnival Corporation Ltd
CCL
$36.1B
| $29.1K | 0.18% |
507,460
| – | – |
|
116
Sarepta Therapeutics
SRPT
$1.66B
| $29.1K | 0.18% |
+220,000
| New | +$20.7M |
|
117
Monolithic Power Systems
MPWR
$65.5B
| $29.1K | 0.17% |
+217,340
| New | +$27.7M |
|
|
MDC
118
DELISTED
M.D.C. Holdings, Inc.
MDC
| $28.4K | 0.17% |
1,076,527
+252,961
| +31% | +$6.58M |
|
|
MIME
119
DELISTED
Mimecast Limited
MIME
| $28.3K | 0.17% |
686,098
-218,999
| -24% | -$8.91M |
|
|
SPLK
120
DELISTED
Splunk Inc
SPLK
| $28K | 0.17% |
282,085
-172,051
| -38% | -$18.7M |
|
121
Keysight
KEYS
$54.5B
| $27.3K | 0.16% |
463,170
-147,859
| -24% | -$8.22M |
|
|
ALXN
122
DELISTED
Alexion Pharmaceuticals
ALXN
| $26.7K | 0.16% |
215,000
+90,000
| +72% | +$10.5M |
|
|
CELG
123
DELISTED
Celgene Corp
CELG
| $25.8K | 0.16% |
325,000
+125,000
| +63% | +$10.4M |
|
124
Texas Instruments
TXN
$255B
| $25.6K | 0.15% |
232,220
-31,848
| -12% | -$3.45M |
|
125
FIVE9
FIVN
$1.77B
| $25.5K | 0.15% |
738,628
-250,768
| -25% | -$8.12M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q2 2018 Portfolio in Review
As of Q2 2018, Polar Capital held 282 positions worth $16.6M, down 100% from $9.92B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Polar Capital withdrew a net $129M in Q2 2018, closing 26 positions and reducing 88 holdings. Its most notable exit was GCI Liberty, Inc. Class A Common Stock (DE), an estimated $37.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 23% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Polar Capital opened a new position in Cognizant worth $54.4K.
- Polar Capital's largest Q2 2018 buy was Cognizant: 688,687 shares worth $54.4K.
- Polar Capital added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2018, an estimated $68M increase.
- Polar Capital's biggest Q2 2018 reduction was Merck, cutting an estimated $56.6M.
- Polar Capital fully exited GCI Liberty, Inc. Class A Common Stock (DE) in Q2 2018, selling an estimated $37.7M.
- Polar Capital's ten largest holdings make up 44% of its $16.6M portfolio in Q2 2018.
- Polar Capital opened 27 new positions and closed 26 in Q2 2018.
- Polar Capital's portfolio value fell 100% quarter-over-quarter to $16.6M.
Based on Polar Capital's 13F filing for Q2 2018, filed 14 Aug 2018.